Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.0045 USD
−24.99 M USD
2.84 M USD
19.75 M
About HCW Biologics Inc.
Sector
Industry
CEO
Hing C. Wong
Website
Headquarters
Miramar
Founded
2018
FIGI
BBG011769443
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HCWB is 0.7700 USD — it has increased by 8.51% in the past 24 hours. Watch HCW Biologics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HCW Biologics Inc. stocks are traded under the ticker HCWB.
HCWB stock has risen by 172.08% compared to the previous week, the month change is a 38.74% rise, over the last year HCW Biologics Inc. has showed a −30.00% decrease.
HCWB reached its all-time high on Jul 20, 2021 with the price of 7.7750 USD, and its all-time low was 0.2761 USD and was reached on Nov 14, 2024. View more price dynamics on HCWB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HCWB stock is 26.13% volatile and has beta coefficient of −0.51. Track HCW Biologics Inc. stock price on the chart and check out the list of the most volatile stocks — is HCW Biologics Inc. there?
Today HCW Biologics Inc. has the market capitalization of 29.12 M, it has increased by 140.87% over the last week.
Yes, you can track HCW Biologics Inc. financials in yearly and quarterly reports right on TradingView.
HCW Biologics Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
HCWB net income for the last quarter is −3.90 M USD, while the quarter before that showed −15.28 M USD of net income which accounts for 74.46% change. Track more HCW Biologics Inc. financial stats to get the full picture.
No, HCWB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 45.00 employees. See our rating of the largest employees — is HCW Biologics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HCW Biologics Inc. EBITDA is −23.67 M USD, and current EBITDA margin is −865.02%. See more stats in HCW Biologics Inc. financial statements.
Like other stocks, HCWB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HCW Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HCW Biologics Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HCW Biologics Inc. stock shows the sell signal. See more of HCW Biologics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.